These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33466615)

  • 1. Serum Calponin 3 Levels in Patients with Systemic Sclerosis: Possible Association with Skin Sclerosis and Arthralgia.
    Kotani H; Yoshizaki A; Matsuda KM; Norimatsu Y; Kuzumi A; Fukayama M; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Asano Y; Oba K; Sato S
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33466615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis.
    Sugimori A; Omori I; Iwasawa O; Saito H; Nakajima H; Matsuno A; Sato S; Sumida H
    Sci Rep; 2024 Mar; 14(1):5572. PubMed ID: 38448661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
    Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
    Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum CXCL12 levels with arthropathy in patients with systemic sclerosis.
    Ikawa T; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
    Int J Rheum Dis; 2021 Feb; 24(2):260-267. PubMed ID: 33252843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.
    Stochmal A; Czuwara J; Zaremba M; Rudnicka L
    Arch Dermatol Res; 2020 Aug; 312(6):453-458. PubMed ID: 31667578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
    Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
    Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis.
    Fukayama M; Yoshizaki A; Fukasawa T; Ebata S; Kuzumi A; Yoshizaki-Ogawa A; Asano Y; Oba K; Sato S
    J Dermatol; 2020 Nov; 47(11):1287-1292. PubMed ID: 32686186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity.
    Yoshizaki A; Komura K; Iwata Y; Ogawa F; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Clin Immunol; 2009 Mar; 29(2):180-9. PubMed ID: 18825489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Soluble CD163 and its association with various disease parameters in patients with systemic sclerosis.
    Hassan WA; Baraka EA; Elnady BM; Gouda TM; Fouad N
    Eur J Rheumatol; 2016 Sep; 3(3):95-100. PubMed ID: 27733938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage.
    Ogawa F; Shimizu K; Hara T; Muroi E; Hasegawa M; Takehara K; Sato S
    Clin Exp Rheumatol; 2008; 26(4):659-62. PubMed ID: 18799101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis.
    Bourji K; Meyer A; Chatelus E; Pincemail J; Pigatto E; Defraigne JO; Singh F; Charlier C; Geny B; Gottenberg JE; Punzi L; Cozzi F; Sibilia J
    Free Radic Biol Med; 2015 Oct; 87():282-9. PubMed ID: 26143738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.
    Bălănescu P; Lădaru A; Bălănescu E; Voiosu T; Băicuş C; Dan GA
    J Clin Lab Anal; 2016 Sep; 30(5):368-73. PubMed ID: 26331941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible association of elevated serum collagen type IV level with skin sclerosis in systemic sclerosis.
    Motegi SI; Sekiguchi A; Fujiwara C; Toki S; Ishikawa O
    J Dermatol; 2017 Feb; 44(2):167-172. PubMed ID: 27568491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
    J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
    Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
    Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis.
    Taniguchi T; Asano Y; Akamata K; Aozasa N; Noda S; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):747-53. PubMed ID: 22540429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.